Rayno Life Science Update: CPHD,CSII,ILMN are Big Movers
Biotech Stocks Have Recovered From Early October Lows We have been traveling for two weeks and have not posted new content nor made portfolio changes. Despite a significant correction in the biotech sector in early October when major ETFs (IBB) and funds such as the Fidelity Select Biotech...
Travel Notice//Update 2 10/21
Expect to be back by 10/25 in the meantime see previous two posts. Biotech stocks remain choppy. Hold mode with 10% cash. Big action has moved to Internets and new media. See Raynoreport.com for market updates. ________________............ Futures are up almost 1% as of 8:50a EDT...
Valuation Models for Biopharmaceutical Stocks
Are Biotech Valuations in the "Bubblet" Phase? In September of 2013 we wrote about the valuations of biotechnology companies from an M&A perspective after the acquisition of Onyx Pharmaceuticals (ONXX) by Amgen at a price of $10.4B. We will attempt to develop a model going forward that...
Risk is Rising-Caution in Biopharmaceutical Stocks
Our Indicators Flash a Caution Signal Today No Change in Portfolio Picks If you are not at 10% cash in your biotechnology portfolio it is time to take profits or hedge your portfolio. If your biotech stock did not hit a new high last week you may want to sell it. Risk is rising and a red screen...
Market Sell-Off Accelerating As Shut-Down Drags On Update 10/4 CLDX
Life Science Trading Update 10/4/13 NASDAQ up 0.88% at 3809 Is the market expecting Boehner to settle? Green screen today with most market leaders up about 2%: AMGN, BIIB, PCYC, REGN, VPHM. ETFs up in the 1% range. DX and Tools Movers: GHDX, ILMN. Mid and small-cap biopharmaceuticals:...